LLY · 10-Q · 2026Q2 · Full report

Manufacturing and Capacity Expansion

ELI LILLY & Co · 2026-08-05 · Importance 40 · Surprise 42

Lilly has undertaken significant manufacturing expansion initiatives to support anticipated demand for current and prospective incretin products. Additional capacity is expected to become operational over the next several years. The company states that global facility investments have increased capital expenditures and will result in meaningfully higher capital expenditures in the near term.